Melatonin ameliorated okadaic-acid induced Alzheimer-like lesions

Acta Pharmacologica Sinica

Volumn 25, Issue 3, 2004, Pages 276-280

  Wang, Yi Peng ^a   Li, Xian Tao ^a   Liu, Shi Jie ^a   Zhou, Xin Wen ^a   Wang, Xiao Chuan ^a   Wang, Jian Zhi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alzheimer disease; Melatonin; Neurofilament proteins; Okadaic acid; Protein phosphatase

Indexed keywords

CYTOSKELETON PROTEIN; MELATONIN; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE;

ALZHEIMER DISEASE; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MICROTUBULE; MICROTUBULE ASSEMBLY; MITOCHONDRION; NEUROFILAMENT; PROTECTION; PROTEIN PHOSPHORYLATION;

ALZHEIMER DISEASE; CELL SURVIVAL; HUMANS; MELATONIN; MICROTUBULES; MITOCHONDRIA; NEUROBLASTOMA; NEUROFILAMENT PROTEINS; NEUROPROTECTIVE AGENTS; OKADAIC ACID; PHOSPHORYLATION; TUMOR CELLS, CULTURED;

EID: 1542284110     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Iqbal K, Alonso AC, Gondal JA, Gong CX, Haque N, Khatoon S, et al. Mechanisms of neurofibrillary degeneration and pharmacologic therapeutic approach. J Neurol Transmission 2000; 59: 213-22
2. Tanzi RE, Bertram L. New frontiers in Alzheimer's disease genetics. Neuron 2001; 32: 181-4.
3. Pappolla MA, Sos M, Omar AR, Bick RJ, Hickson-Bick DLM, Reiter RJ, et al. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J Neurosci 1997; 17: 1683-90.
4. Pappolla M, Bozner P, Soto C, Shao H, Robakis NK, Zagorski M, et al. Inhibition of Alzheimer β-fibrillogenesis by melatonin. J Biol Chem 1998; 273: 185-8.
5. Poeggeler B, Miravalle L, Zagorski MG, Wisniewski T, Chyan YJ, Zhang Y, et al. Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Aβ peptide. Biochemistry 2001; 40: 14995-5001.
6. Liu SJ, Wang JZ. Alzheimer-like tau phosphorylation induced by wortmannin in vivo and its attenuation by melatonin, Acta Pharmacol Sin 2002; 23: 183-7.
7. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999; 20: 279-307.
8. Xu H, Gouras GK, Greenfield JP, Vincent B, Naslund J, Mazzarelli L, et al. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nat Med 1998; 4: 447-51.
9. Zheng H, Xu H, Wang H, Uljon SN, Gross R, Hardy K, et al. Modulation of β-amyloid accumulation by estrogen in Alzheimer's disease mouse models. J Neurochem 2002; 80: 191-6.
10. Gilles RJ, Didier N, Denton M. Determination of cell number in monolayer cultures. Anal Biochem 1986; 159: 109-13.
11. Lian GN, Lei JM, He SS. PASMC proliferation detected by MTT colorimetric assay with ultraviolet and visible spectrophotometers. Acta Univ Med Tongji 2000; 29: 304-305.
12. Mosmaan T. Colorimetric assay cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-6.
13. Bensadoun A, Weinstein D. Assay of protein in the presence of interfering materials. Anal Biochem 1976; 70: 241-250.
14. Hu YY, He SS, Wang XC, Duan QH, Grundke-Iqbal I, Iqbal K, et al. Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer disease patients: an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay. Am J Pathol 2002; 160: 1269-78.
15. Ferrari E, Arcaini A, Gornati R, Pelanconi L, Cravello L, Fioravanti M, et al. Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia. Exp Gerontol 2000; 35: 1239-50.
16. Jean-Louis G, Zizi F, von Gizycki H, Taub H. Effects of melatonin in two individuals with Alzheimer's disease. Percept Mot Skills 1998; 87: 331-9.
17. Liu RY, Zhou JN, van Heerikhuize J, Hofman MA, Swaab DF. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J Clin Endocrinol Metab 1999; 84: 323-7.
18. Reiter RJ. The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Exp Gerontol 1995; 30: 199-212.
19. Reiter RJ, Tan DX, Qi WB. Suppression of oxygen toxicity by melatonin. Acta Pharmacol Sin 1998; 19: 575-81.
20. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocrine J 1993; 1: 57-60.
21. Fernandez JJ, Candenas ML, Souto ML, Trujillo MM, Norte M. Okadaic acid, useful tool for studying cellular processes. Curr Med Chem 2002; 9: 229-62.
22. Schmidt KN, Traenckner EB, Meier B, Baeuerle PA. Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-kappa B. J Biol Chem 1995; 270: 27136-42.
23. Lee KW, Lee HJ, Kang KS, Lee CY. Preventive effects of vitamin C on carcinogenesis. Lancet 2002; 359: 172.
24. Wang JZ, Yung YC, Wang YP, Li XT, Iqbal K, Grundke-Iqbal I. Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in OA-treated SY5Y cells. FEBS Lett 2001; 507: 81-7.
25. Hu YY, He SS, Wang XC, Duan QH, Khatoon S, Grundke-Iqbal I, et al. Elevated level of phosphorylated neurofilament in CSF of AD. Neurosci Lett 2002; 320: 156-60.